Endospore-forming bacteria are ubiquitous, and their endospores can be present in food, in
domestic animals, and on contaminated surfaces. Many spore-forming bacteria have been …

are the only treatments so far developed to avoid recurrent infections (van Nood et al.,
2013). Capable of withstanding heat, desiccation and noxious chemicals, spores transmit C …

Clostridioides difficile, a spore-forming bacterium, is a nosocomial infectious pathogen
which can be found in animals as well. Although various antibiotics and disinfectants were …

Clostridioides difficile is one of the most common nosocomial gastrointestinal pathogens,
and recurrence is a problematic issue because approximately 20–30% of patients …

Endospore-forming bacteria cause a range of important clinical infections. In this chapter,
recent advances in endospore research are summarized. The function of endospore …

Multidrug microbial resistance is risking an annual loss of more than 10 million people'lives
by 2050. Solutions include the rational use of antibiotics and the use of drugs that reduce …

World human population is increasing with an alarming rate; and a variety of new types of
health issues are popping up. For instance, increase in number of drug-resistant bacteria is …

Current antibiotic treatments fail to eliminate the Clostridium difficile (C. difficile) spores and
induce dysbiosis and intestinal inflammation via off-target effect, which causes refractory C …

Bacterial endospores (spores) have a higher intrinsic resistance to microbicides as
compared to other microbial forms, most likely due to their impermeable outer layers and low …

The emergence of widespread antibiotic resistance as an impediment in the treatment of
bacterial diseases is of growing concern. In some instances, clinicians are left with few or no …